Albuquerque, NM, United States of America

Laurie Hudson

USPTO Granted Patents = 5 

Average Co-Inventor Count = 5.6

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2015-2025

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovator Laurie Hudson: Pioneering Modulators of GTPases

Introduction: Laurie Hudson, an accomplished inventor based in Albuquerque, NM, has made significant contributions to the field of molecular science with a total of four patents to her name. Her work focuses on developing innovative solutions for treating various diseases through the modulation of GTPases, which have pivotal roles in numerous health conditions.

Latest Patents: Among her recent patents is a groundbreaking invention that relates to molecules functioning as modulators of the Ras-homologous (Rho) family of small GTPases, including Rac, Cdc42, and Rho GTPases. These modulators serve both as inhibitors and agonists and have promising applications in treating a wide range of diseases, particularly cancers such as medulloblastoma, ovarian, breast, head and neck, testicular, prostate cancers, and B cell lymphoma. Additionally, her patents address sporadic and genetic diseases where Rho GTPases are overexpressed or hyperactivated, including Menkes disease, rheumatoid arthritis, atherosclerosis, diabetes (type I), Huntington's disease, and Alzheimer's disease. Hudson's innovative compounds are also promising in the treatment of specific infections.

Career Highlights: Laurie Hudson's career is distinguished by her impactful research and contributions, particularly through her associations with notable institutions. She has worked with Stc.unm and UNM Rainforest Innovations, where her innovative pursuits led to the development of essential therapeutic molecules. Her dedication to scientific advancement has resulted in patents that not only enhance our understanding of molecular mechanisms but also offer potential pathways for treating debilitating diseases.

Collaborations: Throughout her career, Hudson has collaborated with esteemed colleagues, including Larry A. Sklar and Zurab Surviladze. These collaborations have fostered an environment of innovation and have been instrumental in propelling her research to new heights.

Conclusion: Laurie Hudson exemplifies the spirit of innovation in the life sciences with her contributions to the modulation of GTPases. Her patents reflect a commitment to addressing complex health challenges and showcase the potential of her work in developing novel therapeutic strategies. As she continues to push the boundaries of scientific inquiry, Laurie Hudson remains a vital figure in the field of molecular research, contributing to advancements that hold promise for many patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…